A Look At Concentrix (CNXC) Valuation After New Earnings Results And 2026 Guidance Update

Concentrix (CNXC) has drawn fresh attention after first quarter revenue reached US$2,500.39 million and net income came in at US$21.59 million, alongside new guidance for second quarter and full year 2026 revenue and operating income.

See our latest analysis for Concentrix.

Despite the recent earnings update, Concentrix’s 1-day and 7-day share price returns of 2.63% and 3.22% sit against a 30-day share price return decline of 20.96% and a 1-year total shareholder return decline of 41.84%. This points to short-term momentum trying to recover within a much weaker long-term picture as investors reassess both growth potential and risk around the new guidance, dividend, buybacks, and recent board appointments.

If this kind of re rating story has your attention, it can be useful to compare with other names benefiting from AI and automation trends by checking out 36 AI infrastructure stocks

With the share price down sharply over 1 year, but trading at a large discount to analyst targets and intrinsic estimates, is Concentrix an undervalued GenAI enabled CX player, or is the market already pricing in its future growth?

Most Popular Narrative: 43.9% Undervalued

With Concentrix last closing at $27.27 against a narrative fair value of $48.60, the widely followed view sees a sizeable valuation gap to its modeled worth.

The synergies from the Webhelp acquisition and integration are expected to yield margin expansion, with anticipated savings boosting non-GAAP operating margins over time. This contributes to both profitability and cash flow improvements.

Read the complete narrative.

Curious what sits behind that margin upgrade and cash flow story? The narrative leans heavily on rising profitability, steadier revenue growth, and a sharply different future earnings profile.

Result: Fair Value of $48.60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there is still clear execution risk, with modest revenue growth and high debt near US$4.9b. Both factors are capable of undermining the margin and buyback driven thesis.

Find out about the key risks to this Concentrix narrative.

Next Steps

Mixed signals like these often spark debate. Move quickly, look through the details yourself, and weigh up the 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Concentrix is on your radar, do not stop there. Broaden your watchlist with other ideas that match different styles, return goals, and risk levels.

• Target higher income potential by reviewing companies in the 13 dividend fortresses that could suit a yield focused approach.
• Hunt for potential mispriced opportunities by scanning the 59 high quality undervalued stocks that pair quality fundamentals with compressed valuations.
• Prioritize capital protection by checking the 68 resilient stocks with low risk scores for stocks that score well on resilience and financial strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com